Largest pharmaceuticals by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
AbbVie has the lowest figure of the 61 pharmaceuticals ranked by net assets, at -CHF 2.8B, followed by BridgeBio Pharma (-CHF 1.8B) and Cytokinetics (-CHF 556.1M). Figures as of 18 Nov 2026, 15:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- Lowest
- AbbVie-CHF 2.8B
- Median
- CHF 740.3M
- Combined market value
- CHF 4.29T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AbbVieABBV · Health Care | -CHF 2.8B | CHF 429.5B | CHF 242.96 | 1.58% down | 26% up | ||
| 2 | BridgeBio PharmaBBIO · Health Care | -CHF 1.8B | CHF 12.8B | CHF 65.50 | 1.16% up | 17% up | ||
| 3 | CytokineticsCYTK · Health Care | -CHF 556.1M | CHF 6B | CHF 43.33 | 0.48% down | 20% down | ||
| 4 | PTC TherapeuticsPTCT · Health Care | -CHF 173.1M | CHF 4.3B | CHF 50.94 | 0.12% up | 20% down | ||
| 5 | Ascendis PharmaASND · Health Care | -CHF 152.3M | CHF 15B | CHF 228.47 | 0.07% down | 28% up | ||
| 6 | VeradermicsMANE · Health Care | -CHF 102M | CHF 4.4B | CHF 104.13 | 1.69% down | 233% up | ||
| 7 | Amneal PharmaceuticalsAMRX · Health Care | -CHF 59.7M | CHF 6.3B | CHF 18.21 | 2.27% up | 83% up | ||
| 8 | Axsome TherapeuticsAXSM · Health Care | CHF 74.4M | CHF 5.9B | CHF 111.71 | 2.53% down | 7% down | ||
| 9 | Travere TherapeuticsTVTX · Health Care | CHF 96.8M | CHF 4.1B | CHF 42.30 | 1.81% down | 44% up | ||
| 10 | Rhythm PharmaceuticalsRYTM · Health Care | CHF 117.2M | CHF 6.8B | CHF 98.15 | 0.16% down | 13% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | CHF 265.3M | CHF 5B | CHF 77.04 | 0.62% down | 31% up | ||
| 12 | ErascaERAS · Health Care | CHF 274.1M | CHF 3.9B | CHF 11.09 | 5.26% down | 403% up | ||
| 13 | Definium TherapeuticsDFTX · Health Care | CHF 280.2M | CHF 3.3B | CHF 24.08 | 2.79% down | 169% up | ||
| 14 | Arrowhead PharmaceuticalsARWR · Health Care | CHF 392.9M | CHF 5.2B | CHF 36.68 | 1.22% up | 10% up | ||
| 15 | Oruka TherapeuticsORKA · Health Care | CHF 397.9M | CHF 5.5B | CHF 81.24 | 0.04% up | 241% up | ||
| 16 | Ionis PharmaceuticalsIONS · Health Care | CHF 412.3M | CHF 3.8B | CHF 22.95 | 0.96% up | 64% down | ||
| 17 | Dianthus TherapeuticsDNTH · Health Care | CHF 416M | CHF 4.1B | CHF 72.99 | 0.45% down | 113% up | ||
| 18 | ABIVAXABVX · Health Care | CHF 425.8M | CHF 6.2B | CHF 70.68 | 2.13% up | 27% down | ||
| 19 | Edgewise TherapeuticsEWTX · Health Care | CHF 440.3M | CHF 3.8B | CHF 34.40 | 2.93% down | 88% up | ||
| 20 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CHF 478.5M | CHF 6.4B | CHF 80.88 | 0.87% up | 126% up | ||
| 21 | Madrigal PharmaceuticalsMDGL · Health Care | CHF 508.1M | CHF 8.1B | CHF 349.00 | 1.90% down | 24% down | ||
| 22 | Protagonist TherapeuticsPTGX · Health Care | CHF 518.2M | CHF 6.9B | CHF 105.06 | 0.04% down | 46% up | ||
| 23 | Cogent BiosciencesCOGT · Health Care | CHF 536.5M | CHF 4.2B | CHF 23.98 | 2.15% up | 20% down | ||
| 24 | Corcept TherapeuticsCORT · Health Care | CHF 546.1M | CHF 6.3B | CHF 57.60 | 2.48% down | 8% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | CHF 546.3M | CHF 8.1B | CHF 53.78 | 1.72% up | 107% up | ||
| 26 | Summit TherapeuticsSMMT · Health Care | CHF 555.4M | CHF 7.3B | CHF 9.12 | 1.41% up | 36% down | ||
| 27 | Spyre TherapeuticsSYRE · Health Care | CHF 603M | CHF 7.6B | CHF 80.34 | 1.58% up | 286% up | ||
| 28 | InsmedINSM · Health Care | CHF 623M | CHF 22.1B | CHF 100.86 | 1.83% down | 40% down | ||
| 29 | Belite BioBLTE · Health Care | CHF 649.6M | CHF 5.4B | CHF 133.60 | 0.48% up | 31% up | ||
| 30 | Alnylam PharmaceuticalsALNY · Health Care | CHF 665.3M | CHF 17.3B | CHF 129.29 | 2.01% down | 66% down | ||
| 31 | Praxis Precision MedicinesPRAX · Health Care | CHF 740.3M | CHF 7.2B | CHF 257.75 | 0.22% up | 61% up | ||
| 32 | Legend BiotechLEGN · Health Care | CHF 844.8M | CHF 2.7B | CHF 13.69 | 0.81% up | 42% down | ||
| 33 | Ligand PharmaceuticalsLGND · Health Care | CHF 857.6M | CHF 5B | CHF 251.38 | 1.49% up | 43% up | ||
| 34 | AlkermesALKS · Health Care | CHF 1.5B | CHF 6.6B | CHF 39.23 | 2.38% up | 58% up | ||
| 35 | ZoetisZTS · Health Care | CHF 2.8B | CHF 28.7B | CHF 70.61 | 0.33% up | 29% down | ||
| 36 | Dr. Reddy's LaboratoriesRDY · Health Care | CHF 3.4B | CHF 10.5B | CHF 12.64 | 1.35% up | 5% up | ||
| 37 | Jazz PharmaceuticalsJAZZ · Health Care | CHF 3.6B | CHF 13.1B | CHF 204.75 | 0.90% up | 37% up | ||
| 38 | BeOne MedicinesONC · Health Care | CHF 3.7B | CHF 38.9B | CHF 340.98 | 2.13% down | 17% up | ||
| 39 | Roivant SciencesROIV · Health Care | CHF 3.8B | CHF 23.8B | CHF 32.87 | 0.72% up | 90% up | ||
| 40 | GenmabGMAB · Health Care | CHF 4.9B | CHF 26.8B | CHF 43.41 | 0.89% down | 70% up | ||
| 41 | GrifolsGRFS · Health Care | CHF 4.9B | CHF 4.9B | CHF 7.19 | 1.22% down | 1% up | ||
| 42 | BioMarin PharmaceuticalBMRN · Health Care | CHF 5.1B | CHF 9.8B | CHF 50.61 | 2.60% up | 11% up | ||
| 43 | Elanco Animal HealthELAN · Health Care | CHF 5.5B | CHF 11.1B | CHF 22.21 | 1.90% up | 20% up | ||
| 44 | United TherapeuticsUTHR · Health Care | CHF 6B | CHF 20.6B | CHF 483.04 | 1.90% down | 23% up | ||
| 45 | Teva Pharmaceutical IndustriesTEVA · Health Care | CHF 6.7B | CHF 41.8B | CHF 35.80 | 0.36% down | 74% up | ||
| 46 | Royalty PharmaRPRX · Health Care | CHF 8.2B | CHF 33.2B | CHF 57.79 | 0.18% down | 78% up | ||
| 47 | ViatrisVTRS · Health Care | CHF 12.4B | CHF 20B | CHF 17.46 | 1.30% up | 96% up | ||
| 48 | Bristol-Myers SquibbBMY · Health Care | CHF 15.6B | CHF 103.4B | CHF 50.58 | 2.20% down | 34% up | ||
| 49 | Vertex PharmaceuticalsVRTX · Health Care | CHF 15.7B | CHF 113.9B | CHF 449.09 | 0.28% down | 27% up | ||
| 50 | GSKGSK · Health Care | CHF 18.3B | CHF 82.6B | CHF 41.21 | 0.73% down | 6% up | ||
| 51 | Eli LillyLLY · Health Care | CHF 22.4B | CHF 1.04T | CHF 1,171.41 | 1.84% down | 35% up | ||
| 52 | Novo NordiskNVO · Health Care | CHF 24.3B | CHF 147.4B | CHF 33.43 | 2.56% down | 17% down | ||
| 53 | Regeneron PharmaceuticalsREGN · Health Care | CHF 26.4B | CHF 83.4B | CHF 806.18 | 0.15% down | 36% up | ||
| 54 | NovartisNVS · Health Care | CHF 38.9B | CHF 249.2B | CHF 131.93 | 1.66% down | 25% up | ||
| 55 | Takeda PharmaceuticalTAK · Health Care | CHF 39.2B | CHF 57.5B | CHF 18.00 | 1.32% down | 54% up | ||
| 56 | AstraZenecaAZN · Health Care | CHF 41B | CHF 233.9B | CHF 150.82 | 1.85% down | 2% up | ||
| 57 | Abbott LaboratoriesABT · Health Care | CHF 43.9B | CHF 151.7B | CHF 87.56 | 0.81% down | 17% down | ||
| 58 | Merck & CoMRK · Health Care | CHF 44.3B | CHF 290.1B | CHF 117.69 | 2.63% down | 51% up | ||
| 59 | SanofiSNY · Health Care | CHF 66.8B | CHF 95.7B | CHF 39.86 | 0.53% down | 4% down | ||
| 60 | Johnson & JohnsonJNJ · Health Care | CHF 68.7B | CHF 557.8B | CHF 231.73 | 1.37% down | 38% up | ||
| 61 | PfizerPFE · Health Care | CHF 72.9B | CHF 135.4B | CHF 23.76 | 1.02% down | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 0.8430 CHF).
Questions and answers
Which pharmaceuticals have the lowest net assets?
AbbVie (-CHF 2.8B), BridgeBio Pharma (-CHF 1.8B) and Cytokinetics (-CHF 556.1M) have the lowest net assets of the 61 pharmaceuticals ranked here as of 18 Nov 2026, 15:56 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by net assets.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by net assets have a combined market value of CHF 4.29T as of 18 Nov 2026, 15:56 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceuticals by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.